arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CANNAPHARMARX, INC.

CPMD

— Price unavailable

16 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

CANNAPHARMARX, INC. demonstrates solid fundamentals with strength in Return on Common Equity (%). Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin -245.8%

ROIC 8.8% ↘

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.36M

— —

Net Income Profit after all expenses

$-11.13M

↓ -401.8% —

FCF / Share Free cash flow per share

$-0.01

↑ +78.8% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
EPS Growth YoY (%)	—	—	-66.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	3.4% Caution ↑ Caution Improving Year-over-year change in net income	55.6% Excellent ↑ Excellent Improving Year-over-year change in net income	2.7% Caution ↑ Caution Improving Year-over-year change in net income	-560.9% Weak ↑ Weak Improving Year-over-year change in net income	-46550.2% Weak ↓ Weak Declining Year-over-year change in net income	99.3% Excellent ↑ Excellent Improving Year-over-year change in net income	91.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-195.2% Weak ↑ Weak Improving Year-over-year change in net income	-4114.2% Weak ↓ Weak Declining Year-over-year change in net income	52.3% Excellent Excellent Year-over-year change in net income	-98.4% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	—	—	78.8% Excellent Excellent Year-over-year change in free cash flow	-133.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	-245.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1738%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
FCF Margin (%) (%)	-58.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.07x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.17x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.03x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.22x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.12x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	8.8% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	10.3% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	30.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	23.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	130.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-329.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	333.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	0.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	104.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1702.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	—	27.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	74.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	77.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	462624.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-47.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-96.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2618.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-165.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-99.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-60281.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-96628.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-746680.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-388408.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	585600.0% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	36.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+146%)	-30.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-302%)	49.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+228%)	68.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+356%)	226.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1407%)	—	—	0.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-95%)	104.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+597%)	—	—	32.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+116%)	100.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+567%)	100.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+567%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Interest Coverage (x)	-1.71x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-0.94x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.28x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.32x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-2375.63x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4277.70x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-1.80K	$-650.00	$-2.32K	$-27.77K	$-334.97K	$-1.55K	$-464.12K	$0.00	$0.00	$-2.62K	$-1.61M	—	$-25.00	$-25.00	$-100.00	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	—	—	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	—	—	$0.04	$0.12	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	—	$-0.01	$-0.03	$-0.01	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.05	$-0.03	$-0.06	$-0.10	$-0.19	$0.13	$-0.02	$-0.05	$-0.05	$-0.04	$-0.02	$-0.12	$-0.03	$-0.01	$0.00	$-0.08
Tangible Book Value per Share (USD)	$-0.05	$-0.03	$-0.06	$-0.10	$-0.19	$-0.04	$-0.34	$-0.05	$-0.05	$-0.04	$-0.02	$-0.12	$-0.03	$-0.01	$0.00	$-0.08
Basic Weighted Avg Shares (shares)	—	—	211.04M	74.69M	40.70M	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Working Capital (USD)	$-30.28M	$-17.53M	$-17.07M	$-13.01M	$-17.08M	$-2.02M	$-3.15M	$-964.30K	$-957.67K	$-684.54K	$-290.93K	$-292.03K	$-197.63K	$-99.56K	—	—
Total Equity (USD)	$-30.15M	$-12.15M	$-17.34M	$-12.93M	$-8.80M	$4.85M	$-286.30K	$-964.30K	$-957.67K	$-684.54K	$-288.23K	$-292.03K	$-197.63K	$-99.56K	$100.00	$-576.30K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$1.36M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—
Depreciation Expense (USD)	—	—	$12.84K	$2.71K	$1.54K	$779.00	$0.00	$0.00	$0.00	$12.03K	$3.02K	—	—	—	—	—
Net Income, GAAP (USD)	$-11.13M	$3.69M	$-8.53M	$-8.83M	$-19.89M	$-20.45M	$-3.09M	$-6.63K	$-1.00M	$-11.74M	$-3.98M	$-94.41K	$-197.73K	$-99.66K	$575.40K	—
Operating Cash Flow (USD)	$-789.10K	$-2.27M	$-1.45M	$-2.41M	$-563.57K	$-3.79M	$-941.14K	$0.00	$-22.38K	$-2.55M	$-1.54M	—	$-23.02K	$-12.10K	$0.00	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 62 quarters

CANNAPHARMARX, INC.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CPMD with peers